CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Bayer

Johnny Ivanyi, Global Head of Distribution Operations

Impact of Digital Transformation on Supply Chain

Johnny Ivanyi

Johnny Ivanyi

Johnny Ivanyi is currently works as a Global Head of Distribution Operations at Bayer. He is responsible for leading the Global Distribution Operational Excellence strategy and transforming logistics across the regions by identifying, assessing, and implementing innovative, best-in-class strategy methods and new technologies such as Global Transportation Management Solutions (TMS), Global Warehousing Management Solutions (WMS), Last Mile Visibility, and Logistics Smart Centers, including Business Intelligence and Data Analytics. Additionally, Johnny oversaw transformation efforts that resulted in cost savings, distinct customer experiences, and a competitive edge while fostering strong stakeholder connections and creating external collaborations.


In an interview with CIOReview Magazine, Johnny Ivanyi, Global Head of Distribution Operations at Bayer talks about evolution of supply chain management due to digital transformation.


What are some of the key aspects Bayer focuses on?


Bayer is a Life Science firm with a more than 150-year history and primary capabilities in the fields of health care and agriculture. The corporation currently focuses on three key aspects in terms of global distribution.


First and foremost, we are concentrating our efforts on digital transmission and the installation of new systems to support digital day-to-day business activities. So at, Bayer we are deploying and expanding the TMS transportation management system in partnership with a partner, Blue Gender, which is a market leader in its field. Currently, TMS is available in more than 25 countries, with plans to expand to another 20 in the near future. As a result, by the time this deployment comes to a close on February 23, we will touch about 90 countries using TMS technology. This will help in the integration of the transportation process, from planning to execution of payment incorporated within a tight formation. Getting real-time visibility into delivery in the final mile is the second pillar on which we are concentrating our efforts in three geographic regions: North America, Asia Pacific, and Latin America.


And at the end, the most important aspect we are focusing on is summarizing the data and insights the to analyze the company's performance. Having a holistic understanding of the organization help in the continuous improvement of the organization's performance. Moreover, one can also evaluate customer experience, which helps maintain long-term relationships with clients.


How has the supply chain industry evolved through the years?


International logistics is the most significant development we are seeing in the supply chain right now. Two years ago, our primary focus was on the domestic market and bringing a product to market directly through our client. However, as the business evolves, we must now examine how we transport raw materials between the various regions and countries we have throughout the world. So, as a firm, we at Bayer are focusing on how we can improve the end-to-end experience for our customers.


We at Bayer are focusing on how we can improve the end-to-end experience for our customers


What would be your piece of advice for your fellow peers and leaders?


One of the most important pieces of advice is emphasizing employee knowledge transformation rather than focusing solely on system and process enhancement. Employees' poor knowledge of new implementation will not provide any form of advantage to the organization. Therefore giving proper training for employees is essential in organizational transformation. Additionally, change management remains a crucial component in supply chain organizations for any new initiative, deployment, or restructure as it is required to overcome the inertia that people exhibit when they are not involved in the decision-making or driving of the change and have no notion how they will be impacted.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/impact-of-digital-transformation-on-supply-chain-nwid-881.html